Fed buying spree could move to long end of yield curve: analysts

By Karen Pierog CHICAGO (Reuters) - The Federal Reserve may shift more of its buying to the long end of the yield curve, analysts say, as the Treasury market braces for a surge in supply to finance relief efforts in the wake of the coronavirus pandemic. Such a move, which is not expected before the central bank's September meeting, would avert a potential mismatch in Treasury supply and demand and help stabilize long-end rates.

Reuters July 30, 2020 00:06:26 IST
Fed buying spree could move to long end of yield curve: analysts

Fed buying spree could move to long end of yield curve analysts

By Karen Pierog

CHICAGO (Reuters) - The Federal Reserve may shift more of its buying to the long end of the yield curve, analysts say, as the Treasury market braces for a surge in supply to finance relief efforts in the wake of the coronavirus pandemic.

Such a move, which is not expected before the central bank's September meeting, would avert a potential mismatch in Treasury supply and demand and help stabilize long-end rates. The central bank will conclude its latest monetary policy meeting on Wednesday afternoon.

In March, the U.S. Congress passed the $2.3 trillion CARES Act and the Fed ramped up its Treasury buying. Its purchases have been concentrated on the shorter end of the yield curve, with maturities in the 10-year and longer range accounting for only 22% of the Fed's Treasury holdings as of last week.

If the Fed does not change the current amount and composition of its purchases in the face of increased supply of Treasuries during the remainder of 2020, "the supply-demand mismatch could pressure long-end rates," according to TD Securities analysts, who said they expect more Fed buying in the 20- to 30-year maturity range.

"Not only will more traditional (quantitative easing) help stabilize long-end rates, but it will help further compress real yields and widen break-evens," the analysts said in a recent report.

The Democrat-led U.S. House passed a $3 trillion relief bill in May and Senate Republicans on Monday unveiled a $1 trillion aid package.

Tiffany Wilding, PIMCO's North American economist, said a doubling of the weighted average duration of Fed purchases would bring more accommodation and more downward pressure on yields.

"Overall, our expectation is that what the Fed takes out the Treasury will basically issue because we are seeing a dramatic increase in Federal government deficits as a result of the various coronavirus stimulus bills," she added.

Roberto Perli, partner and head of global policy research at Cornerstone Macro, said shifting purchases toward the long end would make sense given that short-term yields "are well anchored by expectations that the funds rate will stay at zero for years."

"It would make sense to concentrate purchases at the longer end, where rates are less anchored – term premiums would be more responsive, and the Fed could get a greater bang for its buck," he said.

(Reporting By Karen Pierog; editing by Ira Iosebashvili and Dan Grebler)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Business

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports

(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment

China bans German pork imports after African swine fever case
Business

China bans German pork imports after African swine fever case

SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.